Ting-ting J. Yu
Shiyan Key Laboratory Of Natural Medicine Nanoformulation Research, Hubei Key Laboratory Of Embryonic Stem Cell Research, Renmin Road No. 30
Shiyan, 442000, China
Shiyan, 442000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
OTUD3-mediated deubiquitination licenses TEX264 to orchestrate ER-phagy for KDM5B degradation in teniposide lung cancer therapy.
Journal: European journal of pharmacology
Published: November 10, 2025
Using Metal-Organic Framework Nanoparticles for Targeted Codelivery of Bortezomib and Iron Ions to Mitochondrial TOM20 to Induce Ferroptosis for Colorectal Cancer Treatment.
Journal: Molecular pharmaceutics
Published: July 17, 2025
Suppression of NRF2 by photodynamic action to enhance bortezomib-triggered DNA damage for synergistic colorectal cancer therapy.
Journal: Journal of photochemistry and photobiology. B, Biology
Published: January 27, 2025
Cepharanthine triggers ferroptosis through inhibition of NRF2 for robust ER stress against lung cancer.
Journal: European journal of pharmacology
Published: May 12, 2024
Long non-coding RNA LOXL1-AS1: a potential biomarker and therapeutic target in human malignant tumors.
Journal: Clinical and experimental medicine
Published: March 26, 2024
Dihydroartemisinin-driven TOM70 inhibition leads to mitochondrial destabilization to induce pyroptosis against lung cancer.
Journal: Phytotherapy research : PTR
Published: January 15, 2024
B-Myb deficiency boosts bortezomib-induced immunogenic cell death in colorectal cancer.
Journal: Scientific reports
Published: December 28, 2023
Cepharanthine-mediated endoplasmic reticulum stress inhibits Notch1 via binding GRP78 for suppressing hepatocellular carcinoma metastasis.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: December 02, 2023
Dihydroartemisinin-driven selective anti-lung cancer proliferation by binding to EGFR and inhibition of NRAS signaling pathway-induced DNA damage.
Journal: Scientific reports
Published: November 23, 2023
Cepharanthine synergizes with photodynamic therapy for boosting ROS-driven DNA damage and suppressing MTH1 as a potential anti-cancer strategy.
Journal: Photodiagnosis and photodynamic therapy
Published: September 08, 2023
A Dihydroartemisinin-Loaded Nanoreactor Motivates Anti-Cancer Immunotherapy by Synergy-Induced Ferroptosis to Activate Cgas/STING for Reprogramming of Macrophage.
Journal: Advanced healthcare materials
Published: May 15, 2023
Up-regulation of ABCG2 by MYBL2 deletion drives Chlorin e6-mediated photodynamic therapy resistance in colorectal cancer.
Journal: Photodiagnosis and photodynamic therapy
Published: February 19, 2023
Last Updated: 09/26/2026